Health care costs associated with hepatocellular carcinoma: a population-based study.
about
Burden of disease and cost of chronic hepatitis C infection in CanadaCost-utility analysis of nonalcoholic steatohepatitis screening.Transitioning to highly effective therapies for the treatment of chronic hepatitis C virus infection: a policy statement and implementation guideline.Improved Survival in Patients with Viral Hepatitis-Induced Hepatocellular Carcinoma Undergoing Recommended Abdominal Ultrasound Surveillance in Ontario: A Population-Based Retrospective Cohort Study.Trends in relative survival in patients with a diagnosis of hepatocellular carcinoma in Ontario: a population-based retrospective cohort study.Patterns of treatment and costs of intermediate and advanced hepatocellular carcinoma management in four Italian centersThe need for treatment scale-up to impact HCV transmission in people who inject drugs in Montréal, Canada: a modelling study.Pricey pills for an even pricier problem.Trends in health care utilization and costs attributable to hepatocellular carcinoma, 2002-2009: a population-based cohort study.Healthcare Costs Related to Treatment of Hepatocellular Carcinoma Among Veterans With Cirrhosis in the United States.The Geography of Primary Hepatic Neoplasms Treatments in Canada: Changes in Latitudes and Changes in Attitudes.Cost-effectiveness analysis of potentially curative and combination treatments for hepatocellular carcinoma with person-level data in a Canadian setting.Liver Transplantation is a Preferable Alternative to Palliative Therapy for Selected Patients with Advanced Hepatocellular Carcinoma.Immune-Mediated Therapies for Liver Cancer.Direct costs of care for hepatocellular carcinoma in patients with hepatitis C cirrhosis.Gastrointestinal Complications of Obesity.A microsimulation cost-utility analysis of alcohol screening and brief intervention to reduce heavy alcohol consumption in Canada.The Economic Burden of Hospital-Acquired Clostridium difficile Infection: A Population-Based Matched Cohort Study.Cost-effectiveness analysis of treatment with non-curative or palliative intent for hepatocellular carcinoma in the real-world setting.Healthcare costs associated with hepatocellular carcinoma and the value of care.Confirming the timing of phase-based costing in oncology studies: a case example in advanced melanoma.Hepatocellular Carcinoma: A Decade of Hospitalizations and Financial Burden in the United States.Health economic assessment of Gd-EOB-DTPA MRI versus ECCM-MRI and multi-detector CT for diagnosis of hepatocellular carcinoma in China.Estimates and predictors of health care costs of esophageal adenocarcinoma: a population-based cohort study.
P2860
Q26849591-A876B986-13FA-45BB-BF78-DB6CB77B48B2Q30385602-436E8566-6FD7-447C-A6CB-F3C0E05DD922Q34524584-F883714E-2F4D-4CA3-8250-AF28C3277EA4Q35785156-CDBAD431-01A5-4D18-BB61-603A7FC63E6EQ36045931-F6E3BDA8-1FB5-4DD1-B1AE-CDF25EE1F60AQ36208355-C60A8EE2-1A6D-44F2-88D2-E87912E76890Q36286654-F88B2BF8-98BD-4353-BDA4-84298685025AQ36751083-8C3F57FB-5B1D-4F03-86D6-EBA7D88CB4CAQ36989118-E79FF60D-1970-406E-867E-633C5DE695F9Q38399579-C58B5DD0-2729-4BBA-BA3A-FACFB3340F13Q38621100-379978D9-9DAC-4651-B5C7-27F2B386101FQ38632696-AB163B3B-A62C-44C8-907C-444E23E0E820Q38979742-D719D966-0C27-4E5D-8BC6-D15AE0F4FACBQ39144327-EFB1729F-2E25-4D83-9F66-A7E7F24F5987Q40159136-DC86D8B8-2C49-485A-8B73-12A102FF2E6FQ40338492-A81AF7A7-40E9-4401-9B8D-81158D004CD3Q41205797-ED989E57-60BB-4D6F-B5A2-D99E8F596AC8Q42102020-7BFEBB59-A104-4B28-97A7-D5172D12F62CQ42706768-18CA3D39-33D1-4617-B364-6B5E2144F631Q44059861-6B058276-23CF-47F2-BBF0-E0D8F40BBC99Q47653890-22D40CCC-AF08-4CAA-8BD3-7ED47CF84E78Q47701162-05E1BE04-B785-427D-BC59-778541D89E24Q48259378-44237D4E-BDCD-4988-8E9A-A2A296030AAFQ55434774-1054C444-2404-4D8A-B361-189E7588B052
P2860
Health care costs associated with hepatocellular carcinoma: a population-based study.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Health care costs associated with hepatocellular carcinoma: a population-based study.
@en
Health care costs associated with hepatocellular carcinoma: a population-based study.
@nl
type
label
Health care costs associated with hepatocellular carcinoma: a population-based study.
@en
Health care costs associated with hepatocellular carcinoma: a population-based study.
@nl
prefLabel
Health care costs associated with hepatocellular carcinoma: a population-based study.
@en
Health care costs associated with hepatocellular carcinoma: a population-based study.
@nl
P2093
P2860
P50
P356
P1433
P1476
Health care costs associated with hepatocellular carcinoma: a population-based study.
@en
P2093
Craig C Earle
Eric Yoshida
Jordan J Feld
Michael A Campitelli
Morris Sherman
Wanrudee Isaranuwatchai
P2860
P304
P356
10.1002/HEP.26231
P407
P577
2013-03-15T00:00:00Z